State of New Jersey Common Pension Fund D - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 82 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
State of New Jersey Common Pension Fund D ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$580,000
-12.8%
93,5000.0%0.00%0.0%
Q1 2019$665,000
-16.7%
93,5000.0%0.00%
-33.3%
Q4 2018$798,000
-57.4%
93,5000.0%0.00%
-57.1%
Q3 2018$1,872,000
-22.5%
93,5000.0%0.01%
-22.2%
Q2 2018$2,415,000
+8.1%
93,5000.0%0.01%0.0%
Q1 2018$2,235,000
-29.5%
93,5000.0%0.01%
-25.0%
Q4 2017$3,169,000
+60.1%
93,5000.0%0.01%
+50.0%
Q3 2017$1,979,000
+21.0%
93,5000.0%0.01%
+14.3%
Q2 2017$1,635,000
-0.1%
93,5000.0%0.01%0.0%
Q1 2017$1,636,000
+3.5%
93,5000.0%0.01%0.0%
Q4 2016$1,580,000
+3.0%
93,5000.0%0.01%0.0%
Q3 2016$1,534,000
+8.3%
93,5000.0%0.01%
+16.7%
Q2 2016$1,416,000
+4.7%
93,5000.0%0.01%0.0%
Q1 2016$1,352,000
-74.5%
93,500
-50.0%
0.01%
-45.5%
Q4 2015$5,296,000
+238.4%
187,000
+100.0%
0.01%
+57.1%
Q3 2015$1,565,000
-36.2%
93,5000.0%0.01%
-22.2%
Q2 2015$2,452,000
+50.0%
93,5000.0%0.01%
+50.0%
Q1 2015$1,635,000
+0.7%
93,5000.0%0.01%0.0%
Q4 2014$1,624,000
-6.7%
93,5000.0%0.01%
-14.3%
Q3 2014$1,741,000
+1.9%
93,5000.0%0.01%0.0%
Q2 2014$1,709,00093,5000.01%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 984,329$6,999,0004.03%
Broadfin Capital, LLC 2,469,894$17,561,0003.63%
Healthcare Value Capital, LLC 100,000$711,0002.74%
ARMISTICE CAPITAL, LLC 2,744,000$19,510,0001.07%
DELTEC ASSET MANAGEMENT LLC 536,836$3,817,0000.84%
SECTORAL ASSET MANAGEMENT INC 808,924$5,751,0000.69%
Mosaic Family Wealth, LLC 91,314$649,0000.26%
Worth Venture Partners, LLC 59,740$425,0000.24%
EMERALD ADVISERS, LLC 626,247$4,453,0000.18%
EMERALD MUTUAL FUND ADVISERS TRUST 565,319$4,019,0000.16%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders